Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

ClinPhone accounts give Parexel a hangover

August 18, 2009 Research and Development Clinphone

Accounting errors at recently-acquired ClinPhone pegged back Parexel's operating profits in its latest quarterly reports, and it will be some …
News

GSK starts first trials for H1N1 vaccine in Germany

August 17, 2009 Research and Development, Sales and Marketing GSK, h1n1, vaccines

GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …
News

Genzyme says Cerezyme shortages could last longer than expected

August 17, 2009 Research and Development, Sales and Marketing Gaucher, Genzyme

The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …
News

Vulnerable groups first in line for UK swine flu jabs

August 14, 2009 Research and Development, Sales and Marketing NHS, h1n1

The first 11 million people to receive jabs against the H1N1 virus have been announced by the government, ready for …
News

Animal rights attacks were terrorism not activism, says Vasella

August 13, 2009 Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Novartis chief executive Daniel Vasella has spoken for the first time of his shock at the arson attack on his …
News

AZ signs antibiotic deal with Forest Laboratories

August 13, 2009 Research and Development, Sales and Marketing Antibiotics, Forest

AstraZeneca has struck a deal with Forest Laboratories to co-develop and commercialise ceftaroline, an anti-infective drug in phase III. The …
News

Authorised generics deals likely here to stay, says analyst

August 12, 2009 Research and Development, Sales and Marketing generics

The practice of branded drugmakers paying rivals to keep generics off the market after product patent expiry – known as …
News

EMEA makes adverse drug reaction research a priority

August 12, 2009 Research and Development, Sales and Marketing Europe, drug safety

Adverse drug reaction in hyperactive children has been made a key research priority for next year by the European Medicines …
News

New FDA head aims for aggressive enforcement

August 11, 2009 Research and Development, Sales and Marketing FDA, US, drug safety

The new head of US regulator the FDA has set out a vision to support public health, through tighter laws …
News

Skills council for pharma

August 11, 2009 Research and Development, Sales and Marketing Jobs, training

The UK pharmaceutical sector is set to get its own body dedicated to identifying and addressing key skills issues. A …
News

Contract research news in brief

August 11, 2009 Research and Development CRO, Omnicom

Pharmafocus presents its periodic round-up of developments in the contract research sector, including updates from Pharm-Olam, OmniComm, SIRO, Ecron Acunova …
News

Charles River cuts forecasts as profits slump

August 11, 2009 Research and Development Charles River, preclinical

Contract preclinical testing specialist Charles River Laboratories saw its second-quarter sales drop 12.5% to $308 million as demand from pharmaceutical …
News

Sanofi submits FDA application for swine flu vaccine

August 10, 2009 Research and Development, Sales and Marketing Sanofi-Aventis, h1n1

Sanofi Pasteur has filed with US regulators a supplemental license application for its vaccine to protect against the H1N1 pandemic …
News

Doubts about funding for ‘Innovation Pass’

August 10, 2009 Research and Development, Sales and Marketing ABPI, NHS, NICE

The new fast-tracking system announced to help accelerate uptake of innovative new treatments in the UK, could be held back …
News

TNF blockers must carry children’s cancer warning

August 7, 2009 Research and Development, Sales and Marketing FDA, RA, TNF

The FDA has ruled that TNF blocker drugs should carry new warnings of the increased risk of certain cancers for …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026